Health Trials

Molecular Inflammation Board at the Center for Personalized Medicine

ConditionsPsoriasis (PsO)Psoriasis ArthritisInflammatory Bowel Disease (Crohn's Disease and Ulcerative Colitis)Spondylarthropathies
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorUniversity Hospital Tuebingen

About this trial

Molecular Inflammation Board at the Center for Personalized Medicine

Eligibility criteria

Qualifiers

Chronic inflammatory disorder (PsO, PsA, SpA, IBD)

Given informed consent

18 years of age

Disqualifiers

No capacity to consent

Trial design

Treatments tested in this trial

  • Biologic Agent

Treatment groups

No treatment groups listed

Sponsors and collaborators

University Hospital Tuebingen

Lead sponsor

University Hospital Freiburg

Collaborator

University Hospital Heidelberg

Collaborator

University Hospital Ulm

Collaborator

Source ClinicalTrials.gov